Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Clin Cancer Res. 2016 Aug 29;23(5):1263–1273. doi: 10.1158/1078-0432.CCR-16-1237

Table 1.

Clinical annotation and PDX characteristics

PDX
model
Clinical Annotation PDX characterization
Histologic
subtype
Source # of prior lines
of
chemotherapy
Prior
platinum
Germline
BRCA
status
PAX8
(IHC)
WT1
(IHC)
Pan
CK
(IHC)
BROCA
mutations
PDX
model
plasma
CA125
DF09 HGSOC Ascites 0 No Unknown Positive Positive Positive Not performed Positive
DF14 HGSOC Ascites 5 Yes Unknown Positive Positive Positive Not performed Positive
DF20 HGSOC Ascites 0 No Unknown Positive Positive Positive TP53, PTEN,
PPM1D
Positive
DF59 HGSOC Ascites 7 Yes BRCA1
5385insC
Positive Positive Positive Not performed Positive
DF68 HGSOC Ascites 5 Yes BRCA1
Q563X
Positive Positive Positive TP53, BRCA1,
PTEN (copy
loss)
Positive
DF83 HGSOC Ascites 4 Yes Unknown Positive Negative Positive TP53,
CDKN2A
(copy loss)
Positive
DF86 HGSOC Ascites 6 Yes BRCA1
del exons
21–24
Positive Positive Positive TP53, BRCA1,
APC
Positive
DF101 HGSOC Pleural
fluid
2 Yes BRCA1
187delAG
Positive Positive Positive TP53, BRCA1,
NBN, PTEN
(copy loss)
Positive
DF106 HGSOC Ascites 1 Yes Unknown Positive Positive Positive TP53,
CDKN2A
(copy loss)
Positive
DF118 HGSOC Ascites 1 Yes Unknown Positive Positive Positive TP53 Positive
DF149 HGSOC Ascites 0 (previously
treated for
breast cancer)
No Wild type Positive Patchy Positive TP53 Positive
DF172 Mixed serous
and
endometrioid
Ascites 2 Yes Unknown Positive Patchy Positive TP53, RET,
RAD51C
Positive
DF181 HGSOC Ascites 7 Yes Wild type Negative Negative Positive TP53, BRIP1 Negative
DF216 Adenoca Ascites 2 Yes Wild type Positive Positive Positive TP53 Positive